Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy
暂无分享，去创建一个
A. Walker | M. Maggini | R. Da Cas | R. Raschetti | G. Traversa | F. Menniti‐Ippolito | R. Cas | Roberto Raschetti | Alexander M. Walker
[1] S. Hill,et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis , 1996, BMJ.
[2] S. Greenland. Dose‐Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis , 1995, Epidemiology.
[3] A. Walker,et al. GASTRODUODENAL TOXICITY OF DIFFERENT NONSTEROIDAL ANTIINFLAMMATORY DRUGS , 1995, Epidemiology.
[4] A. Walker,et al. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. , 1992, Archives of internal medicine.
[5] S. Gabriel,et al. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. , 1991, Annals of internal medicine.
[6] R. N. Brogden,et al. Ketorolac , 2012, Drugs.